ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aldington, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aldington, S.
Eur Respir J 2008; 31:280-286
Copyright ©ERS Journals Ltd 2008

Cannabis use and risk of lung cancer: a case–control study

S. Aldington1, M. Harwood1, B. Cox2, M. Weatherall3, L. Beckert1, A. Hansell4, A. Pritchard1, G. Robinson1, R. Beasley1,5 on behalf of the Cannabis and Respiratory Disease Research Group

1 Medical Research Institute of New Zealand, 3 Wellington School of Medicine & Health Sciences, Wellington, 2 Hugh Adam Cancer Epidemiology Unit, University of Otago, Dunedin, New Zealand, 4 Imperial College London, London, and 5 University of Southampton, Southampton, UK.

CORRESPONDENCE: R. Beasley, Medical Research Institute of New Zealand, PO Box 10055, Wellington, New Zealand. Fax: 64 44729224. E-mail: Richard.Beasley{at}mrinz.ac.nz

Keywords: Cannabis, case–control, lung cancer, tobacco

Received: May 31, 2007
Accepted August 21, 2007

The aim of the present study was to determine the risk of lung cancer associated with cannabis smoking.

A case–control study of lung cancer in adults ≤55 yrs of age was conducted in eight district health boards in New Zealand. Cases were identified from the New Zealand Cancer Registry and hospital databases. Controls were randomly selected from the electoral roll, with frequency matching to cases in 5-yr age groups and district health boards. Interviewer-administered questionnaires were used to assess possible risk factors, including cannabis use. The relative risk of lung cancer associated with cannabis smoking was estimated by logistic regression.

In total, 79 cases of lung cancer and 324 controls were included in the study. The risk of lung cancer increased 8% (95% confidence interval (CI) 2–15) for each joint-yr of cannabis smoking, after adjustment for confounding variables including cigarette smoking, and 7% (95% CI 5–9) for each pack-yr of cigarette smoking, after adjustment for confounding variables including cannabis smoking. The highest tertile of cannabis use was associated with an increased risk of lung cancer (relative risk 5.7 (95% CI 1.5–21.6)), after adjustment for confounding variables including cigarette smoking.

In conclusion, the results of the present study indicate that long-term cannabis use increases the risk of lung cancer in young adults.




This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
S. Dubey and C. A. Powell
Update in Lung Cancer 2008
Am. J. Respir. Crit. Care Med., May 15, 2009; 179(10): 860 - 868.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
R. A. Sewell, A. J. Cohn, and M. C. Chawarski
Doubts about the role of cannabis in causing lung cancer
Eur. Respir. J., September 1, 2008; 32(3): 815 - 816.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
A. S. Reece
Cannabis and lung cancer
Eur. Respir. J., July 1, 2008; 32(1): 238 - 239.
[Full Text] [PDF]

Home page
 CMAJHome page
L. Degenhardt MPsych(Cli and W. D. Hall PhD
The adverse effects of cannabinoids: implications for use of medical marijuana
Can. Med. Assoc. J., June 17, 2008; 178(13): 1685 - 1686.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the European Respiratory Society.